Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 86: 681-686, 1999;
8750-7587/99 $5.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jansen, G. F. A.
Right arrow Articles by Basnyat, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jansen, G. F. A.
Right arrow Articles by Basnyat, B.
Vol. 86, Issue 2, 681-686, February 1999

Cerebral vasomotor reactivity at high altitude in humans

Gerard F. A. Jansen, Anne Krins, and Buddha Basnyat

Department of Anesthesiology, Academic Medical Centre, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands; and Nepal International Clinic, Naxaul, Kathmandu, Nepal

The purpose of this study was twofold: 1) to determine whether at high altitude cerebral blood flow (CBF) as assessed during CO2 inhalation and during hyperventilation in subjects with acute mountain sickness (AMS) was different from that in subjects without AMS and 2) to compare the CBF as assessed under similar conditions in Sherpas at high altitude and in subjects at sea level. Resting control values of blood flow velocity in the middle cerebral artery (VMCA), pulse oxygen saturation (SaO2), and transcutaneous PCO2 were measured at 4,243 m in 43 subjects without AMS, 17 subjects with AMS, 20 Sherpas, and 13 subjects at sea level. Responses of CO2 inhalation and hyperventilation on VMCA, SaO2, and transcutaneous PCO2 were measured, and the cerebral vasomotor reactivity (VMR = Delta VMCA/PCO2) was calculated as the fractional change of VMCA per Torr change of PCO2, yielding a hypercapnic VMR and a hypocapnic VMR. AMS subjects showed a significantly higher resting control VMCA than did no-AMS subjects (74 ± 22 and 56 ± 14 cm/s, respectively; P < 0.001), and SaO2 was significantly lower (80 ± 8 and 88 ± 3%, respectively; P < 0.001). Resting control VMCA values in the sea-level group (60 ± 15 cm/s), in the no-AMS group, and in Sherpas (59 ± 13 cm/s) were not different. Hypercapnic VMR values in AMS subjects were 4.0 ± 4.4, in no-AMS subjects were 5.5 ± 4.3, in Sherpas were 5.6 ± 4.1, and in sea-level subjects were 5.6 ± 2.5 (not significant). Hypocapnic VMR values were significantly higher in AMS subjects (5.9 ± 1.5) compared with no-AMS subjects (4.8 ± 1.4; P < 0.005) but were not significantly different between Sherpas (3.8 ± 1.1) and the sea-level group (2.8 ± 0.7). We conclude that AMS subjects have greater cerebral hemodynamic responses to hyperventilation, higher VMCA resting control values, and lower SaO2 compared with no-AMS subjects. Sherpas showed a cerebral hemodynamic pattern similar to that of normal subjects at sea level.

mountain sickness; Sherpa; transcranial Doppler; transcutaneous carbon dioxide


This article has been cited by other articles:


Home page
 ChestHome page
R. B. Schoene
Illnesses at High Altitude
Chest, August 1, 2008; 134(2): 402 - 416.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
R. J. Thomas, B. R. Rosen, C. E. Stern, J. W. Weiss, and K. K. Kwong
Functional imaging of working memory in obstructive sleep-disordered breathing
J Appl Physiol, June 1, 2005; 98(6): 2226 - 2234.
[Abstract] [Full Text] [PDF]

Home page
 Exp PhysiolHome page
V. E. Claydon, L. J. Norcliffe, J. P. Moore, M. Rivera, F. Leon-Velarde, O. Appenzeller, and R. Hainsworth
Cardiovascular responses to orthostatic stress in healthy altitude dwellers, and altitude residents with chronic mountain sickness
Exp Physiol, January 1, 2005; 90(1): 103 - 110.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
H. A. Ghofrani, F. Reichenberger, M. G. Kohstall, E. H. Mrosek, T. Seeger, H. Olschewski, W. Seeger, and F. Grimminger
Sildenafil Increased Exercise Capacity during Hypoxia at Low Altitudes and at Mount Everest Base Camp: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial
Ann Intern Med, August 3, 2004; 141(3): 169 - 177.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
J. C. Kolb, P. N. Ainslie, K. Ide, and M. J. Poulin
Effects of five consecutive nocturnal hypoxic exposures on the cerebrovascular responses to acute hypoxia and hypercapnia in humans
J Appl Physiol, May 1, 2004; 96(5): 1745 - 1754.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
A. P. Blaber, T. Hartley, and P. J. Pretorius
Effect of acute exposure to 3,660 m altitude on orthostatic responses and tolerance
J Appl Physiol, August 1, 2003; 95(2): 591 - 601.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
N. Gruhn, F. S. Larsen, S. Boesgaard, G. M. Knudsen, S. A. Mortensen, G. Thomsen, and J. Aldershvile
Cerebral Blood Flow in Patients With Chronic Heart Failure Before and After Heart Transplantation
Stroke, November 1, 2001; 32(11): 2530 - 2533.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
G. F. A. Jansen, A. Krins, B. Basnyat, A. Bosch, and J. A. Odoom
Cerebral Autoregulation in Subjects Adapted and Not Adapted to High Altitude
Stroke, October 1, 2000; 31(10): 2314 - 2318.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online